Nervgen Pharma Corporation.

NGEN·NASDAQ·$2.13Share Price as of 11/2·$172MMarket Cap as of 11/2

Financials

40-F/AAnnual report (Canadian, amended)10/16/26 40-FAnnual report (Canadian)03/31/26

Disclosures

6-K/AForeign issuer report (amended)10/16/26 6-KForeign issuer report09/25/26 6-KForeign issuer report09/24/26 6-KForeign issuer report08/13/26 6-KForeign issuer report07/02/26

Prospectuses and Registrations

F-10Prospectus / registration05/26/26 F-XProspectus / registration05/26/26 S-8Registration of securities for employees05/07/26 S-8Registration of securities for employees01/23/26 F-10/AProspectus / registration01/07/26

Proxies

No matching filings.

Ownership

No matching filings.

Other

SUPPLSUPPL07/02/26 EFFECTRequest for effectiveness05/26/26 SUPPLSUPPL05/26/26 SUPPLSUPPL05/22/26 SUPPLSUPPL05/21/26